| Preventability of adverse drug events involving multiple drugs using publicly available clinical decision support tools. | |
| | |
MedLine Citation:
|
PMID: 22261944 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Purpose The results of a retrospective evaluation of the frequency and preventability of adverse drug events (ADEs) involving multiple drugs among hospital inpatients are reported. Methods Data collected in a previous cohort study of 180 actual ADEs and 552 potential ADEs (PADEs) at six community hospitals in Massachusetts were analyzed to determine the frequency and types of multiple-drug ADEs and the extent to which the ADEs might have been prevented using publicly available clinical decision-support (CDS) knowledge bases. None of the hospitals had a computerized prescriber-order-entry system at the time of data collection (January 2005-August 2006). Results A total of 17 ADEs (rate, 1.4 per 100 admissions) and 146 PADEs (rate, 12.2 per 100 admissions) involving multiple drugs were identified. The documented events were related to drug duplication (n = 126), drug-drug interaction (n = 21), additive effects (n = 14), and therapeutic duplication (n = 7) or a combination of those factors. The majority of actual ADEs were due to drug-drug interactions, most commonly involving opioids, benzodiazepines, or cardiac medications; about 75% of the PADEs involved excessive drug doses resulting from order duplication or the prescribing of combination drugs with overlapping ingredients, usually products containing acetaminophen and an opioid. It was determined that 5 (29.4%) of the ADEs and 131 (89.7%) of the PADEs could have been detected through the use of the evaluated CDS tools. Conclusion A substantial number of actual ADEs and PADEs in the community hospital setting may be preventable through the use of publicly available CDS knowledge bases. |
| | |
Authors:
|
Adam Wright; Joshua Feblowitz; Shobha Phansalkar; Jialin Liu; Allison Wilcox; Carol A Keohane; Diane L Seger; Meryl Bloomrosen; Gilad J Kuperman; David W Bates |
Related Documents
:
|
9727664 - Class ic antiarrhythmic drugs, flecainide and pilsicainide, produce st segment elevatio... 14688634 - Oral class iii antiarrhythmics: what is new? 11742564 - Carvedilol and vesnarinone: new antiarrhythmic approach in heart failure therapy. 8676554 - Idiopathic ventricular fibrillation initiated by a short-coupled ventricular premature ... 10558014 - Explosion in the medicine chest. 16704754 - Dehydroepiandrosterone sulphate interferes with the abbott architect direct immunoassay... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists Volume: 69 ISSN: 1535-2900 ISO Abbreviation: Am J Health Syst Pharm Publication Date: 2012 Feb |
Date Detail:
|
Created Date: 2012-01-20 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9503023 Medline TA: Am J Health Syst Pharm Country: United States |
Other Details:
|
Languages: eng Pagination: 221-7 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Syndrome of inappropriate antidiuretic hormone associated with moxifloxacin.
Next Document: Description of an academic teaching rotation for postgraduate year 1 pharmacy residents.